10.01.25 -- Gain Access To Tailored Bioanalytic Services.

Pedro Morales, Director, Scientific Advisor of Biologics Analytical Services, explores how Catalent delivers tailored solutions through deep expertise and advanced capabilities.

Our team of analytical experts provides experience, efficiency, and technical proficiency in the development/validation of analytical methodology and GMP testing support for your project.

Uncover how Integrated Unprocessed Bulk testing — including viral assays, NGS, and TEM — can safeguard product safety, minimize contamination risks, and streamline biologics development.

Get support for drug substances and product modalities through all product phases and specialty laboratory services, including in-house microbiology, raw materials, and analytical development.

With cutting-edge technologies, regulatory excellence, and a commitment to quality, we provide seamless support tailored to your specific needs.

Our Analytical team follows a rigorous three-step approach — Risk Assessment, Confirmatory Testing, and Remediation Planning — to ensure that pharmaceutical products are safe for human use.

Caddy Hobbs, Ph.D., takes an in-depth look at our analytical services, which support the full drug development lifecycle — from early development through to commercial manufacturing.

Leverage rapid, high-quality discovery bioanalysis to streamline your drug development process, optimize lead compounds, and meet evolving timelines with confidence.

Our state-of-the-art laboratories, equipped with cutting-edge processes and analytical instrumentation, enable us to efficiently conduct route scouting, accelerate process development, and optimize reaction conditions.

Discover a remote monitoring system that provides rapid, data-driven support to minimize downtime and ensure efficient responses in high-performance life science environments.

Explore the results collected when a platform designed with ML-guided GPS engineering was applied to develop a lead molecule targeting a mechanism in neuronal disease.

Join 1,000+ pharma, biotech, and drug delivery professionals at the PODD: Partnership Opportunities in Drug Delivery Conference conference, October 27–28 in Boston. Featuring 10 technology tracks, pharma company spotlights, 1:1 partnering, and more. Attendees will also hear from leaders at companies including AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GSK, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, and others. Register at PODDConference.com with code LSL20 for 20% off.